ANI Pharmaceuticals
ANIP
#4819
Rank
ยฃ1.37 B
Marketcap
ยฃ61.33
Share price
-1.17%
Change (1 day)
37.26%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.46 Billion

According to ANI Pharmaceuticals's latest financial reports the company's total debt is ยฃ0.46 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.49 B121.79%
2023-12-31ยฃ0.22 B-5.32%
2022-12-31ยฃ0.23 B11.24%
2021-12-31ยฃ0.21 B56.28%
2020-12-31ยฃ0.13 B-3.83%
2019-12-31ยฃ0.14 B-1.75%
2018-12-31ยฃ0.14 B-3.3%
2017-12-31ยฃ0.14 B52.49%
2016-12-31ยฃ97.77 M27.74%
2015-12-31ยฃ76.54 M11.85%
2014-12-31ยฃ68.43 M
2013-12-31N/A-100%
2012-12-31ยฃ4.87 M-56.27%
2011-12-31ยฃ11.15 M-7.16%
2010-12-31ยฃ12.01 M16.59%
2009-12-31ยฃ10.3 M
2000-12-31ยฃ0.33 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Jazz Pharmaceuticals
JAZZ
ยฃ4.07 B 775.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
ยฃ3.84 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.80 B 2,652.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
ยฃ45.64 B 9,709.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
ยฃ0.47 B 3.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ1.96 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
ยฃ6.77 B 1,356.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ24.01 B 5,062.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
ยฃ6.71 B 1,342.14%๐Ÿ‡ฌ๐Ÿ‡ง UK